In natural killer (NK) cells SRC-3 deficiency results in a decreased expression of key T-bet target genes such as Zeb2, Prdm1, and S1pr5, leading to compromised cell maturation, anti-tumor activity and signature phenotype (107). The gene discussed is NCOA3; the disease is neoplasm.